Lombardi Cancer Center / Georgetown University Medical Center is a clinical research site located in Washington D.C., District of Columbia, United States 20007.
Crixeo Health Trust Score: 66/100 (FAIR). This profile has not yet been claimed by the site owner.
Lombardi Cancer Center / Georgetown University Medical Center has participated in 4 clinical trials with 1 currently active.
Therapeutic areas: Urothelial Cancer, HER2 Positive Breast Cancer, Metastatic Colorectal Adenocarcinoma.
Sponsors: Astellas Pharma Global Development, Inc., Seagen Inc..
Trust Score: 66/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Lombardi Cancer Center / Georgetown University Medical Center has a Crixeo Trust Score of 66/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Lombardi Cancer Center / Georgetown University Medical Center has 4 clinical trials on record, with 1 currently active. Their work covers Urothelial Cancer, HER2 Positive Breast Cancer, Metastatic Colorectal Adenocarcinoma.
Lombardi Cancer Center / Georgetown University Medical Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.